Pharmacology and immuno-virologic efficacy of once-a-day HAART in African HIV-infected children: ANRS 12103 phase II trial

• Main Authors: Boubacar Nacro (Author), Emmanuelle Zoure (Author), Hervé Hien (Author), Hassane Tamboura (Author), François Rouet (Author), Adama Ouiminga (Author), Ali Drabo (Author), Souleymane Yameogo (Author), Alain Hien (Author), Hélène Peyriere (Author), Olivier Mathieu (Author), Deborah Hirt (Author), Jean-Marc Treluyer (Author), Joëlle Nicolas (Author), Vincent Foulongne (Author), Michel Segondy (Author), Philippe van de Perre (Author), Serge Diagbouga (Author), Philippe Msellati (Author)
• Format: Book
• Published: The World Health Organization, 2011-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

OBJECTIVE: To assess 12-month survival, pharmacokinetics, immunologic and virologic efficacy, tolerance, compliance and drug resistance in HIV-infected children in Bobo-Dioulasso, Burkina Faso, receiving once-daily highly-active antiretroviral therapy as a combination of didanosine (DDI), lamivudine...